Related Experiment Video
Updated: Feb 4, 2026

Study of the Actin Cytoskeleton in Live Endothelial Cells Expressing GFP-Actin
Published on: November 18, 2011
Polyarginine Peptide R11-Actin Interaction Induces a Domino Effect on Cytoskeleton Remodeling to Suppress Bladder
Zhenghong Liu1, Chuanzan Zhou1, Wentao Xu2
1Urology and Nephrology Center, Department of Urology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang 310014, China.
Abstract:
Cytoskeletal remodeling, particularly actin dynamics, is a central driver of tumor metastasis. However, actin-targeting agents have faced major translational barriers due to poor specificity and the absence of defined druggable sites. Here, we report a bladder tumor-targeting polyarginine peptide, R11, as a precision modulator of actin dynamics capable of disrupting the cytoskeletal architecture of bladder cancer (BCa) to suppress its lung metastasis potently and persistently. R11 directly interacts with actin, weakening the actin-plectin-vimentin/integrin β4 axis and initiating a cascade of cytoskeletal disorganization that ultimately impairs cellular motility and metastatic potential. Remarkably, nanoscale multivalent assemblies of R11 amplify these effects through enhanced multivalent binding to actin. This study unveils a new strategy for cytoskeleton-targeted intervention through peptide-based precision materials, highlighting R11 assemblies as a promising therapeutic platform for the treatment of metastatic BCa and potentially other cytoskeleton-dependent malignancies.
Insights
Researchers developed a peptide, R11, that targets bladder cancer cells. R11 disrupts actin dynamics, effectively suppressing lung metastasis and offering a new therapeutic strategy for metastatic bladder cancer.
Area of Science:
- Oncology
- Cell Biology
- Biomaterials
Background:
- Tumor metastasis is driven by cytoskeletal remodeling, particularly actin dynamics.
- Actin-targeting agents face challenges due to poor specificity and lack of defined druggable sites.
Purpose of the Study:
- To develop a precision modulator of actin dynamics for bladder cancer (BCa) metastasis.
- To investigate the therapeutic potential of a polyarginine peptide, R11, and its assemblies.
Main Methods:
- Utilized a bladder tumor-targeting polyarginine peptide, R11.
- Investigated R11's interaction with the actin-plectin-vimentin/integrin β4 axis.
- Engineered nanoscale multivalent assemblies of R11.
Main Results:
- R11 disrupted cytoskeletal architecture in BCa cells, suppressing lung metastasis.
- R11 directly interacted with actin, weakening key cytoskeletal interactions.
- R11 assemblies demonstrated amplified therapeutic effects through enhanced multivalent binding.
Conclusions:
- R11 peptide assemblies represent a novel therapeutic platform for metastatic bladder cancer.
- This strategy offers precision intervention for cytoskeleton-dependent malignancies.
- R11 shows promise for treating metastatic BCa and other cancers driven by cytoskeletal dynamics.
Related Concept Videos
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Polarity of the Cytoskeleton
Peptide Bonds
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Introduction to the Cytoskeleton
The cytoskeleton is a network of protein filaments present within the cell, having three distinct filaments ̶ microfilaments, microtubules, and intermediate filaments. Each has characteristic features that distinguish them, including the dynamics of their assembly and disassembly, mechanical properties, polarity, and the type of molecular motors associated with them. Earlier, they were thought to be present only in eukaryotic cells; however, their...
Studying the Cytoskeleton

